# Sarepta Therapeutics, Inc.: Form 8-K, filed Feb 14, 2025

- Company: [Sarepta Therapeutics, Inc.](/companies/srpt.md) (CIK 873303)
- Form: 8-K
- Filed: 2025-02-14
- Accepted by EDGAR: Feb 14, 2025, 08:38 ET
- Period: 2025-02-13
- Accession: 0001193125-25-026683
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/873303/000119312525026683/d875089d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/873303/000119312525026683/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 2.03: New direct financial obligation
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/873303/000119312525026683/d875089d8k.htm

Filed Feb 14, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-026683. Last ingested by Listed: Nov 5, 2026, 17:27 ET. No prices; not investment advice.